All In Biotech

Drug Trial Radar · NCT01601847

Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy

Last checked: Nov 20, 2026Latest source record: Jun 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Jan 2013

Primary completion

Mar 12, 2017

Study completion Mar 12, 2017

Sponsor

Lead sponsor
Case Western Reserve UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Office of Dietary Supplements (ODS)
First posted
May 18, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, up to 1 year
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to identify a vitamin D supplementation strategy that best promotes the lung, immune, and overall health of black infants born preterm (28-36 weeks gestational age). This is a high risk population that seems to have unique vitamin D needs, and inappropriate supplementation may promote wheezing or allergy. The results of this study will help form nutritional recommendations for the approximately 100,000 black infants born at 30-36 weeks gestational age in the U.S. every year.

Conditions

  • Wheezing
  • Allergy

Interventions

  • CholecalciferolDietary supplement

    Once the dietary intake of vitamin D has exceeded 200 IU/Day, the infants will receive placebo until they are 6 months of age adjusted for prematurity

  • CholecalciferolDrug

    Infants will receive cholecalciferol 400 IU/day PO until they are 6 months of age adjusted for prematurity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Infants With Recurrent WheezingTime frame: up to 12 months adjusted age

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Montefiore Medical Center

    New York, New York

  • Case Western Reserve University

    Cleveland, Ohio

  • University Hospitals

    Cleveland, Ohio

  • MetroHealth Medical Center

    Cleveland, Ohio

  • Medical University of South Carolina

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.